Pharmacotherapy for schizophrenic inpatients in East Asia – Changes and challenges

References

• Chong MY, Tan CH, Fujii S, Yang SY, Ungvari G, Si T, et al. Antipsychotic drug prescription for Schizophrenia in East Asia: A rationale for change. Psychiatry and Clinical Neurosciences 2004; 58(1)61–67
   PubMed Web of Science ®Google Scholar
• Davies LM, Lewis S, Jones PB, Barnes TR, Gaughran F, Hayhurst K, et al. Cost-effectiveness of first- v. second-generation antipsychotic drugs: Results from a randomised controlled trial in schizophrenia responding poorly to previous therapy. British Journal of Psychiatry 2007; 191: 14–22
   PubMed Web of Science ®Google Scholar
• Fujii S, Maeda K, Shinfuku N. Survey on psychotropic drug prescription pattern in six countries and areas in East Asia. Rinsyo Seizing Iguaçu 2003; 32(6)629–646, (In Japanese)
   Google Scholar
• Fujii S, Shinfuku N. The characteristics of pharmacotherapy for the inpatients with schizophrenia in Japan - Comparison with other countries and regions. Rinsyo Seisin Yakuri 2004; 7(1)3–14, (In Japanese)
   Google Scholar
• Fujii S, Shinfuku N. Utilization of levomepromazine in Japan – Its role as an antipsychotic in psychiatric pharmacotherapy. Rinsyo Seisin Yakuri 2005; 8(8)1227–1238, (In Japanese)
   Google Scholar
• Hung GB, Cheung HK. Predictors of high-dose antipsychotic prescription in psychiatric patients in Hong Kong. Hong Kong Medical Journal 2008; 14(1)35–39
   PubMedGoogle Scholar
• Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, et al. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Archives of General Psychiatry 2006; 63: 1079–1087
   PubMed Web of Science ®Google Scholar
• Law WL, Hui HY, Young WM, You JH. Atypical antipsychotic therapy for treatment of schizophrenia in Hong Kong Chinese patients – A cost analysis. International Journal of Clinical Pharmacopsychiatric Therapy 2007; 45: 264–270
   PubMed Web of Science ®Google Scholar
• Lee C, Wu KH, Habil H, Dyachkova Y, Lee P. Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia. Australia and New Zealand Journal of Psychiatry 2006; 40(5)437–445
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck Perkins, R. A., et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 2005; 353: 1209–1223
   PubMed Web of Science ®Google Scholar
• Rothbard AB, Kuno E, Foley K. Trend in the rate and type of antipsychotic medications prescribed to persons with schizophrenia. Schizophrenia Bulletin 2003; 29(3)531–540
   PubMed Web of Science ®Google Scholar
• Scheen AJ, De Hert MA. Abnormal glucose metabolism in patients treated with antipsychotics. Diabetes and Metabolism 2007; 33(3)169–175
   PubMed Web of Science ®Google Scholar
• Shiloh R, Nutt., Weizman A. Atlas of psychiatric pharmacotherapyRevised. Martin Dunitz, London 2000
   Google Scholar
• Sim K, Su A, Leong JY, Yip K, Chong MY, Fujii S, et al. High dose antipsychotic use in schizophrenia: Findings of the REAP (Research on East Asia Psychotropic Prescriptions) study. Pharmacopsychiatry 2004a; 37(4)175–179
   PubMed Web of Science ®Google Scholar
• Sim K, Su A, Fujii S, Yang SY, Chong MY, Ungvari GS, et al. Antipsychotic polypharmacy in patients with schizophrenia: A multicentre comparative study in East Asia. British Journal of Clinical Pharmacology 2004b; 58(2)178–183, Erratum in: British Journal of Clinical Pharmacology, 58(5), 564
   PubMed Web of Science ®Google Scholar
• Sim K, Su A, Ungvari GS, Fuji i S, Yang SY, Chong MY, et al. Depot antipsychotic use in schizophrenia: An East Asian perspective. Human Psychopharmacology 2004c; 19: 103–109
   PubMed Web of Science ®Google Scholar
• Sim K, Lee NB, Chua HC, Mahendran R, Fujii S, Yang SY, et al. Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study. British Journal of Clinical Pharmacology 2007; 63: 431–437
   PubMed Web of Science ®Google Scholar
• Swartz MS, Perkins DO, Stroup TS, Davis SM, Capuano G, Rosenheck RA, et al. CATIE Investigators. Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: Findings from the NIMH CATIE study. American Journal of Psychiatry 2007; 2(164)428–436
   Google Scholar
• Tandon R, Belmaker, Wagner F, Gattaz J, Lopez-Ibor, Jr, Okasha A, et al. the Section of Pharmacopsychiatry, World Psychiatric Association World Psychiatric Association 2008, Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophrenia Research, 100(1–3), 20–38
   Google Scholar
• Tang YL, Ma PX, Jiang F, Chen Q, Wang CY, Cai ZJ, et al. Clozapine in China. Pharmacopsychiatry 2008; 41: 1–9
   PubMed Web of Science ®Google Scholar
• Uchida N, Chong MY, Tan CH, Nagai H, Tanaka M, Lee MS, et al. International study on antidepressant prescription pattern at 20 teaching hospitals and major psychiatric institutions in East Asia: Analysis of 1898 cases from China, Japan, Korea, Singapore and Taiwan. Psychiatry and Clinical Neurosciences 2007; 61: 522–528
   PubMed Web of Science ®Google Scholar
• WHO (World Health Organization). The ICD Classification of Mental and Behavioral Disorder. Clinical Description and Diagnostic Guidelines. World Health Organization, Geneva 1992
   Google Scholar
• WHO. Collaborating Centre for Drug Statistic Methodology. Guidelines for ATC index with DDDs. WHO, Oslo 2002
   Google Scholar
• WHO. WHO Mental Health Atlas 2005. World Health Organization, Geneva 2005
   Google Scholar
• Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS, Gerevich J. Clinical and social determinants of psychotropic drug prescription for schizophrenia outpatients in China. Progress in Neuropsychopharmacology and Biological Psychiatry 2007; 31: 756–60
   PubMed Web of Science ®Google Scholar
• Xiang YT, Weng YZ, Leung CM, Tang WK, Sandor UG. Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia. Human Psychopharmacology 2007; 22: 173–180
   PubMed Web of Science ®Google Scholar
• Yoshimura R, Inoue M, Sasaki H, Kuroki H, Shinfuku N. Gaps in psychotropic prescription pattern between various areas in Japan. Seishin Iryo 2005; 38: 17–25, 21 (In Japanese)
   Google Scholar
• Yoshimura R, Okamoto T, Nakamura J, Tateno M, Otsuka K, Takahashi H, et al. Prescription pattern of antipsychotic drugs for schizophrenic inpatients in Japan: Research on East Asia Psychotropic Prescription Pattern- Antipsychotics study. Psychiatry and Clinical Neurosciences 2006; 60(6)778–779
   PubMed Web of Science ®Google Scholar